2 Top Nanotech Stocks to Buy for the Second Half of 2021

NYSE: TMO | Thermo Fisher Scientific Inc. News, Ratings, and Charts

TMO – The demand for nanotechnology is growing with its numerous applications in industries from healthcare to agriculture. Because many countries and companies are increasingly focusing on nanoscience and nanotechnology innovations to drive some of the world’s biggest breakthroughs, the industry holds solid growth prospects. So, we believe nanotech stocks Thermo Fisher Scientific (TMO) and Onto Innovations (ONTO) are good bets now. Read on.

Nanotechnology is emerging rapidly, outpacing other technologies at a breakneck speed, with potential uses in various sectors, including computer and electronics, healthcare, cosmetics, textile, energy, and agriculture, to mention a few. Interestingly, its growing use in the healthcare sector has enabled researchers to develop more innovative and effective drugs.

Rapid developments in healthcare technology and growing government spending on biotechnology and pharmaceutical R&D are anticipated to drive the nanotech sector’s growth. The global nanotechnology market is expected to reach $126.8 billion by 2027, growing at a 12.9% CAGR.

Given the accelerating growth of the nanotechnology market, we think it may be prudent to bet on fundamentally strong nanotech companies Thermo Fisher Scientific Inc. (TMO) and Onto Innovations Inc. (ONTO), which have the potential to deliver  huge returns to investors in the coming months.

Thermo Fisher Scientific Inc. (TMO)

TMO provides scientific instrumentation and software services. It develops and distributes various products under the brand names Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services are the four segments through which the Waltham, Mass., company operates.

This month, TMO  opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, California, to meet the rapidly increasing demand for plasmid DNA-based therapies and mRNA-based vaccines. Because  plasmid DNA is being used increasingly as a therapeutic option in gene treatments and vaccinations, the company is well-positioned to see substantial growth in revenues in the coming months.

During the second quarter, ended July 3, 2021, TMO’s revenue increased 34.1% year-over-year to $9.27 billion. The company’s operating income increased 55.5% year-over-year to $2.16 billion over this period. Its net income increased 58.1% year-over-year to $1.83 billion, while its EPS grew 59% from the prior-year quarter to $4.61.

A  $22.12  consensus EPS estimate for the current year represents a 13.1% improvement year-over-year. The $35.66 billion consensus revenue estimate  for 2021 represents a 10.7% increase from the same period last year. The stock has gained 29.7% over the past year and 13.4% year-to-date.

TMO’s POWR Ratings reflect this promising outlook. The company has an overall B rating, which translates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

TMO is also graded  an A  for Growth. In addition, , within the Medical – Diagnostics/Research industry, it is ranked #9 of 55 stocks.

To see more of TMO’s component grades, click here.

Click here to checkout our Healthcare Sector Report for 2021

Onto Innovation Inc. (ONTO)

ONTO is a manufacturer of semiconductor equipment and software technologies. The Flanders, N.J.-based company provides a range of technologies for wafer production, front-end process management, and advanced semiconductor packaging lithography. In addition, the company offers overlay metrology for controlling lithography and etch operations in the compound semiconductor sector.

During the first quarter, ended March 27, 2021, ONTO’s non-GAAP revenue increased 21% year-over-year to $169.28 million. The company’s non-GAAP operating income increased 82.6% year-over-year to $41.87 million. Its non- GAAP net income increased 84.1% year-over-year to $36.34 million, while its non-GAAP EPS increased 87.2% year-over-year to $0.73 over this period.

ONTO is expected to witness 29%  revenue growth for the current year. Its EPS is estimated to increase 64.8% year-over-year to $3.18 in 2021. Over the past year, ONTO’s stock has gained 91.1%. Furthermore, it has gained 41% year-to-date.

ONTO’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to Buy in our POWR Ratings system. The stock also has a B grade for Growth, Momentum, and Quality. In the B-rated Semiconductor & Wireless Chip same industry, it is ranked #35 of 99 stocks.

In total, we rate ONTO on eight different levels. Beyond what we’ve stated above, we have also given ONTO grades for Stability, Sentiment, and Value. Get all the ONTO ratings here.

Click here to checkout our Semiconductor Industry Report for 2021

TMO shares were trading at $532.31 per share on Thursday afternoon, up $4.04 (+0.76%). Year-to-date, TMO has gained 14.41%, versus a 18.83% rise in the benchmark S&P 500 index during the same period.

About the Author: Pragya Pandey

Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
TMOGet RatingGet RatingGet Rating
ONTOGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com

Christmas in July for Stock Investors!

Yes, the S&P 500 (SPY) made new highs again on Tuesday. But really it is the 6X gain for the Russell 2000 small cap index Tuesday...and 12% gain this past week that is grabbing everyone’s attention. Let’s discuss why this is happening...if it will continue...and my 12 favorite stocks to rally in the weeks ahead. Read on for more...

3 Promising Tech Stocks Under $40 for Long-Term Investment

The increasing demand for technology services worldwide fuels the tech industry. Amid this backdrop, it could be wise to buy under $40 tech stocks, such as HP Inc. (HPQ), Box, Inc. (BOX), and Teradata Corp (TDC), for long-term investment. Continue reading…

3 MedTech Stocks to Add to Your Portfolio in July

The MedTech sector’s promising future is driven by technological advances, unceasing demand for medical treatments due to an aging population, and increasing global incidence of diseases. To that end, strong MedTech stocks such as Tactile Systems Technology (TCMD), Electromed (ELMD), and Embecta (EMBC) could be wise portfolio additions in July. Read more...

3 Bank Stocks Benefiting From High Interest Rates

Amid global economic uncertainties, major U.S. banks like JPMorgan (JPM), Wells Fargo & Company (WFC), and PNC Financial Services (PNC) have defied expectations with strong revenue and earnings reports for the second quarter. Considering their robust performance, investing in these stocks could offer stable returns to your portfolio. Read more…

Investor Alert: Load Up on Small Cap Stocks!

Large caps time in the sun is now over and thus no shock that the S&P 500 (SPY) pulled back from recent highs. It is time for small caps to shine which was clear in their nearly 4% gain Thursday even as the Magnificent 7 was bathed in red. Why is this happening? What comes next? And what are the best stocks to own now? The answers to all that and more are shared in the commentary below...

Read More Stories

More Thermo Fisher Scientific Inc. (TMO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TMO News